All Stories

  1. Hyperuricemia in 2025: Epidemiology, Mechanisms, Associated Conditions and Treat-to-target Management

    Article • Indian Journal of Rheumatology, August 2026, SAGE Publications

    Dr Yogendra Nayak

  2. Targeting pulmonary fibrosis through Solanum xanthocarpum phytochemicals: A synergistic network pharmacology and docking investigation

    Article • Computers in Biology and Medicine, July 2026, Elsevier

    Dr Yogendra Nayak

  3. Oligosaccharide prebiotics in functional foods and therapeutics: innovations and challenges

    Article • 3 Biotech, June 2026, Springer Science + Business Media

    Dr Yogendra Nayak

  4. Phytochemicals from Achillea millefolium target NAFLD and NASH: A network pharmacology integrated bioinformatics and molecular docking investigation

    Article • Computational Biology and Chemistry, April 2026, Elsevier

    Dr Yogendra Nayak

  5. Zingiber zerumbet rhizome attenuates bleomycin-induced pulmonary fibrosis by regulating TGF-β1 and TNF/NF-κB signaling to inhibit epithelial-mesenchymal transition and fibroblast activation

    Article • Journal of Ethnopharmacology, February 2026, Elsevier

    Dr Yogendra Nayak

  6. Reimagining Preclinical Research: Zebrafish Models Driving Advances in Pharmacology and Toxicology

    Article • F1000Research, December 2025, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  7. The 4E-BPs as Translational Regulators in Neurological Disorders: Molecular Mechanisms and Therapeutic Potential

    Article • Molecular Neurobiology, November 2025, Springer Science + Business Media

    Dr Yogendra Nayak

  8. Application of Network Pharmacology in Elucidating Molecular Mechanisms of Traditional Drugs for Pulmonary Fibrosis

    Article • Revista Brasileira de Farmacognosia, November 2025, Springer Science + Business Media

    Dr Yogendra Nayak

  9. Exploring acenocoumarol and silodosin in non-small cell lung cancer: Insights into EGFR-linked signaling mechanisms

    Article • F1000Research, September 2025, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  10. Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease

    Article • F1000Research, May 2025, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  11. Fabrication and evaluation of self-assembled folic acid surface modified Nintedanib mixed micelles to treat Idiopathic Pulmonary Fibrosis

    Article • Journal of Drug Delivery Science and Technology, May 2025, Elsevier

    Dr Yogendra Nayak

  12. Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review

    Article • International Immunopharmacology, February 2025, Elsevier

    Dr Yogendra Nayak

  13. Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection

    Article • Scientifica, January 2025, Wiley

    Dr Yogendra Nayak

  14. Flavone-C-glycosides from Cassia auriculata L. as possible inhibitors of phosphodiesterase-5 (PDE5): in vitro , molecular docking and molecular dynamics studies

    Article • Journal of Biomolecular Structure and Dynamics, November 2024, Taylor & Francis

    Dr Yogendra Nayak

  15. Exploring acenocoumarol and silodosin as allosteric EGFR inhibitors for the treatment of non-small cell lung cancer

    Article • F1000Research, November 2024, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  16. Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease

    Article • F1000Research, August 2024, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  17. Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease

    Article • F1000Research, July 2024, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  18. Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis

    Article • F1000Research, June 2024, Faculty of 1000, Ltd.

    Krishnaprasad B, Dr Yogendra Nayak

  19. A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers

    Article • F1000Research, June 2024, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  20. Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis

    Article • F1000Research, March 2024, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  21. A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers

    Article • F1000Research, October 2023, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  22. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies

    Article • F1000Research, September 2023, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  23. Trigonella foenum-graecum L. seed extract modulates biochemical and histomorphological changes in therapeutic model of high-fat diet-fed ovariectomized rats

    Article • 3 Biotech, July 2023, Springer Science + Business Media

    Dr Yogendra Nayak

  24. Scopus based bibliometric and scientometric analysis of occupational therapy publications from 2001 to 2020

    Article • F1000Research, June 2023, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  25. Transforming Wound Management: Nanomaterials and Their Clinical Impact

    Article • Pharmaceutics, May 2023, MDPI AG

    Dr Yogendra Nayak

  26. Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer

    Article • Scientific Reports, May 2023, Springer Science + Business Media

    Dr Yogendra Nayak

  27. Scopus based bibliometric and scientometric analysis of occupational therapy publications from 2001 to 2020

    Article • F1000Research, May 2023, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  28. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis

    Article • Inflammopharmacology, March 2023, Springer Science + Business Media

    Krishnaprasad B, Dr Yogendra Nayak

  29. Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease

    Article • Advanced Pharmaceutical Bulletin, January 2023, MaadRayan Publishing Company

    Dr Yogendra Nayak

  30. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies

    Article • F1000Research, January 2023, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  31. Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment

    Article • Viruses, January 2023, MDPI AG

    Dr Yogendra Nayak

  32. Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer

    Article • Biomaterials Advances, September 2022, Elsevier

    Prof. Dr. Jayalakshmi N. S., Dr Yogendra Nayak

  33. Hybrid nanostructures: Versatile systems for biomedical applications

    Article • Coordination Chemistry Reviews, June 2022, Elsevier

    Dr Yogendra Nayak

  34. Enhancing the oral bioavailability of asenapine maleate with bio-enhancer: An in-silico assisted in-vivo pharmacokinetic study

    Article • Journal of Drug Delivery Science and Technology, April 2022, Elsevier

    Dr Yogendra Nayak

  35. Phytoestrogenic Potential of Resveratrol by Selective Activation of Estrogen Receptor-α in Osteoblast Cells

    Article • Revista Brasileira de Farmacognosia, March 2022, Springer Science + Business Media

    Dr Yogendra Nayak

  36. Prophylactic effect of Trigonella foenum-graecum L. seed extract on inflammatory markers and histopathological changes in high-fat-fed ovariectomized rats

    Article • Journal of Traditional and Complementary Medicine, March 2022, Elsevier

    Dr Yogendra Nayak

  37. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies

    Article • F1000Research, February 2022, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  38. Scopus based bibliometric and scientometric analysis of occupational therapy publications from 2001 to 2020

    Article • F1000Research, February 2022, Faculty of 1000, Ltd.

    Mr Koushik Sau, Dr Yogendra Nayak

  39. Bioanalytical RP-HPLC method validation for resveratrol and its application to pharmacokinetic and drug distribution studies

    Article • Journal of Applied Biology & Biotechnology, February 2022, Journal of Applied Pharmaceutical Science

    Dr Yogendra Nayak

  40. Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis

    Article • Life Sciences, February 2022, Elsevier

    Dr Yogendra Nayak

  41. Effect of Moringa oleifera leaf extract on exercise and dexamethasone-induced functional impairment in skeletal muscles

    Article • Journal of Ayurveda and Integrative Medicine, January 2022, Elsevier

    Dr Yogendra Nayak

  42. Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2021, Elsevier

    Dr Yogendra Nayak

  43. Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Dr Yogendra Nayak

  44. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity

    Article • International Journal of Molecular Sciences, August 2021, MDPI AG

    Dr Yogendra Nayak

  45. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy

    Article • Carbohydrate Polymers, June 2021, Elsevier

    Dr Yogendra Nayak

  46. Mesoporous silica nanoparticles capped with chitosan-glucuronic acid conjugate for pH-responsive targeted delivery of 5-fluorouracil

    Article • Journal of Drug Delivery Science and Technology, June 2021, Elsevier

    Dr Yogendra Nayak

  47. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study

    Article • European Journal of Pharmacology, April 2021, Elsevier

    Dr Yogendra Nayak

  48. Modulation of inflammatory markers by petroleum ether fraction of Trigonella foenum‐graecum L. seed extract in ovariectomized rats

    Article • Journal of Food Biochemistry, March 2021, Wiley

    Dr Yogendra Nayak

  49. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study

    Article • Archives of Medical Research, January 2021, Elsevier

    Dr Yogendra Nayak

  50. In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2

    Article • Pharmaceutical Sciences, November 2020, MaadRayan Publishing Company

    Dr Yogendra Nayak

  51. Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment

    Article • November 2020, Springer Science + Business Media

    Dr Yogendra Nayak

  52. Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19

    Article • F1000Research, September 2020, Faculty of 1000, Ltd.

    Dr Yogendra Nayak

  53. Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance

    Article • Pharmacological Reports, July 2020, Springer Science + Business Media

    Dr Yogendra Nayak

  54. Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer

    Article • Pharmaceutics, June 2020, MDPI AG

    Dr Yogendra Nayak

  55. Development, Optimisation and Validation of RP-HPLC Method for the Quantification of Resveratrol

    Article • Indian Journal of Pharmaceutical Education and Research, August 2019, EManuscript Services

    Dr Yogendra Nayak

  56. Dose-dependent effects of fenugreek seed extract on the biochemical and haematological parameters in high-fat diet-fed rats

    Article • Journal of Taibah University Medical Sciences, August 2019, Elsevier

    Dr Yogendra Nayak

  57. Annona muricata fruit extract protects against diethylnitrosamine-induced hepatocellular cancer in rats

    Article • Asian Pacific Journal of Tropical Medicine, January 2019, Medknow

    Dr Yogendra Nayak

  58. Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting

    Article • Journal of Drug Delivery Science and Technology, April 2018, Elsevier

    Dr Yogendra Nayak

  59. 5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats

    Article • Psychopharmacology, March 2018, Springer Science + Business Media

    Dr Yogendra Nayak

  60. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting

    Article • Life Sciences, August 2017, Elsevier

    Dr Yogendra Nayak

  61. 5-HT6 Receptor Agonist and Antagonist Against β-Amyloid-Peptide-Induced Neurotoxicity in PC-12 Cells

    Article • Neurochemical Research, March 2017, Springer Science + Business Media

    Dr Yogendra Nayak

  62. Modulation of Doxorubicin-Induced Cardiotoxicity by Averrhoa bilimbi extract

    Article • Journal of Young Pharmacists, January 2017, EManuscript Services

    Dr Yogendra Nayak

  63. Development of risperidone liposomes for brain targeting through intranasal route

    Article • Life Sciences, October 2016, Elsevier

    Dr Yogendra Nayak

  64. In vitro Cytotoxicity Activity of Chrysin, Morin and Resveratrol Against MCF-7 Breast Cancer Cell Lines

    Article • Biosciences Biotechnology Research Asia, September 2016, Oriental Scientific Publishing Company

    Dr Yogendra Nayak

  65. Lymphatic Delivery of Anti-HIV Drug Nanoparticles

    Article • Recent Patents on Nanotechnology, June 2016, Bentham Science Publishers

    Dr Yogendra Nayak

  66. Biological activity of a small molecule indole analog, 1-[(1H-indol-3-yl)methylene]-2-phenylhydrazine (HMPH), in chronic inflammation

    Article • Chemico-Biological Interactions, January 2016, Elsevier

    Dr Yogendra Nayak

  67. Synthesis of newer piperidinyl chalcones and their anticancer activity in human cancer cell lines

    Article • Research on Chemical Intermediates, September 2015, Springer Science + Business Media

    Dr Yogendra Nayak

  68. Preparation, Characterization and Pharmacokinetic Study of Nelfinavir Nanocrystals for Oral Bioavailability Enhancement

    Article • Current Nanoscience, April 2015, Bentham Science Publishers

    Dr Yogendra Nayak

  69. Antidiabetic, Antihyperlipidemic and Antioxidant Effects of the Flavonoids

    Article • January 2014, Elsevier

    Dr Yogendra Nayak

  70. Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats

    Article • The Scientific World JOURNAL, January 2014, Hindawi Publishing Corporation

    Dr Yogendra Nayak

  71. Synthesis, Characterization and Antioxidant Activities of Synthetic Chalcones and Flavones

    Article • APCBEE Procedia, January 2012, Elsevier

    Dr Yogendra Nayak

  72. Evaluation of the Antioxidant Activity of Novel Synthetic Chalcones and Flavonols

    Article • International Journal of Chemical Engineering and Applications, January 2012, EJournal Publishing

    Dr Yogendra Nayak

  73. Radioprotective Effect of Ocimum sanctum and Amifostine on the Salivary Gland of Rats After Therapeutic Radioiodine Exposure

    Article • Cancer Biotherapy & Radiopharmaceuticals, December 2011, Mary Ann Liebert Inc

    Dr Yogendra Nayak

  74. Synthesis of 3-methylflavones and their antioxidant and antibacterial activities

    Article • Medicinal Chemistry Research, July 2011, Springer Science + Business Media

    Dr Yogendra Nayak

  75. Chronotherapeutic drug delivery for early morning surge in blood pressure: A programmable delivery system

    Article • Journal of Controlled Release, June 2009, Elsevier

    Dr Yogendra Nayak

  76. Design and synthesis of 2-quinolones as antioxidants and antimicrobials: a rational approach

    Article • Medicinal Chemistry Research, April 2009, Springer Science + Business Media

    Dr Yogendra Nayak

  77. P32. 2-Quinolones for antibacterial and antioxidant activity—A docking study

    Article • January 2008, Elsevier

    Dr Yogendra Nayak

  78. P33. Synthetic flavonoids as potential antioxidant and antimicrobials

    Article • January 2008, Elsevier

    Dr Yogendra Nayak

  79. Gastroprotective effect of swallow root (Decalepis hamiltonii) extract: Possible involvement of H+–K+–ATPase inhibition and antioxidative mechanism

    Article • Journal of Ethnopharmacology, May 2007, Elsevier

    Dr Yogendra Nayak